Vanda Pharmaceuticals Inc.·4

Mar 1, 4:25 PM ET

Reverberi Gian Piero 4

4 · Vanda Pharmaceuticals Inc. · Filed Mar 1, 2019

Insider Transaction Report

Form 4
Period: 2019-02-27
Reverberi Gian Piero
SVP, General Manager Europe
Transactions
  • Award

    Common Stock

    2019-02-27+30,000168,870 total
  • Award

    Employee Stock Option (Right to Buy)

    2019-02-27+70,00070,000 total
    Exercise: $20.62Exp: 2029-02-26Common Stock (70,000 underlying)
Footnotes (2)
  • [F1]Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2020, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
  • [F2]The option vests in forty-eight (48) equal monthly installments from the date of grant, provided the Reporting Person remains continuously employed by the Issuer through each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION